<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Baqiyatallah University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Medical Reviews</JournalTitle>
				<Issn>2345-525X</Issn>
				<Volume>8</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2021</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Postoperative Cardiovascular Morbidity and Management after Lung Surgery: A Retrospective Study and Literature Review</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>3</FirstPage>
			<LastPage>11</LastPage>
			<ELocationID EIdType="pii">128386</ELocationID>
			
<ELocationID EIdType="doi">10.30491/ijmr.2020.234460.1107</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ferdinand-Kalemba Mwinikumah</FirstName>
					<LastName>Kambile</LastName>
<Affiliation>Clinical Resident of Thoracic Surgery, department of faculty surgery with a courses of Anesthesiology and intensive care, Ryazan  State I.P.Pavlov Medical University Ryazan, Russian Federation</Affiliation>
<Identifier Source="ORCID">0000-0003-0933-3496</Identifier>

</Author>
<Author>
					<FirstName>Sergey Nikolaevich</FirstName>
					<LastName>Trushin</LastName>
<Affiliation>Department of Faculty Surgery with Course of Anesthesiology and Resuscitation Science, Ryazan State  I.P.Pavlov Medical University Ryazan, Russian Federation</Affiliation>
<Identifier Source="ORCID">0000-0003-0470-6345</Identifier>

</Author>
<Author>
					<FirstName>Aleksey Vladimirovich</FirstName>
					<LastName>Mikheev</LastName>
<Affiliation>Department of Faculty Surgery with Course of Anesthesiology and Resuscitation Science, Ryazan State I.P.Pavlov Medical University Ryazan, Russian Federation</Affiliation>
<Identifier Source="ORCID">0000-0001-6936-1451</Identifier>

</Author>
<Author>
					<FirstName>Aleksey Sergeivich</FirstName>
					<LastName>Andryushin</LastName>
<Affiliation>Clinical Resident of Thoracic Surgery, department of faculty surgery with a courses of Anesthesiology and intensive care, Ryazan  State I.P.Pavlov Medical University Ryazan, Russian Federation</Affiliation>
<Identifier Source="ORCID">0000-0003-2192-0036</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>06</Month>
					<Day>09</Day>
				</PubDate>
			</History>
		<Abstract>&lt; p&gt;Lung surgeries are considered as important surgical procedures as they go a long way to improve the quality of life in patients suffering from different lung conditions. Multi -factorial etiopathogenesis is attributed to patients who undergo lung surgery as a method of treatment to improve their lives after being diagnosed with certain critical lung diseases. The aim of this review is to ascertain the quality of life and a cross-sectional review of some of the cardiovascular challenges in patients who received lung surgery as a treatment option. In our practice as thoracic specialists, different procedures are recommended as treatment options in variable clinical presentations of diseases of lungs and their surrounding tissues. Every surgical proce dure has its benefits and complications, and what makes a surgical procedure ideal is the availability of alternative management options to resolve any complications after surgery. Ideally, complications are least anticipated although they are highly inevitable. Cardiovascular morbidities are amongst the most common complications after lung surgery. In the present study, 26 patients who had suffered from cardiovascular challenges after lung surgery from December 2019 to January 2020 have been investigated. These compl ications include disturbances of normal heart rhythm (arrhythmia) in 15 (57.7%) patients, ischemic diseases of the heart like myocardial infarction recorded in four (15.4%) patients, cardiac failure caused by thrombo -embolic disease in two (7.7%) patients, and more than one cardiovascular challenge in five (19.2%) patients. These complications occurred between two weeks to one-month postoperatively after lung surgery.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Cardiovascular</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Morbidity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Critical Lung Diseases</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Complications</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lung Surgery</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijmedrev.com/article_128386_751f30e0cee9120148b411a1df1d6d8c.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
